Business / Finance RSS Feed - Business / Finance

NeuroDerm signs definitive investment agreements for $16 million financing round

NeuroDerm signs definitive investment agreements for $16 million financing round

NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that it has signed definitive investment agreements for a $16 million financing round led by certain of its existing investors with the participation of new investors, including The Elias Group. [More]
US Fitness adds Sport & Health to its portfolio of clubs

US Fitness adds Sport & Health to its portfolio of clubs

US Fitness Holdings, LLC announced today it has added Sport & Health to its portfolio of clubs, creating one of the largest health club companies in the country. [More]
Avizia announces closing of equity financing round

Avizia announces closing of equity financing round

Avizia, Inc., a leading provider of cutting-edge telemedicine solutions, today announced that it has closed an equity financing round led by NextGen Angels along with Blu Venture Investors and Middleland Capital. [More]

Cardiva Medical closes private equity financing and senior secured facility with GE Capital

Cardiva Medical, Inc. announced today that it has closed the first two tranches of a $16.5 million Series 3 private equity financing and a $12.5 million senior secured facility with GE Capital. [More]
Genesis HealthCare signs definitive agreement to merge with Skilled Healthcare Group

Genesis HealthCare signs definitive agreement to merge with Skilled Healthcare Group

Genesis HealthCare, one of the nation's largest providers of post-acute care services, today announced that it has signed a definitive agreement to combine with Skilled Healthcare Group, Inc., based in Foothill Ranch, California. [More]
Novartis and Gamida Cell sign Option and Investment Agreements

Novartis and Gamida Cell sign Option and Investment Agreements

​Elbit Imaging Ltd. announced today that Elbit Medical Technologies Ltd., a subsidiary of the Company in which it holds approximately 86% of the voting power, announced that on August 18, 2014, Gamida Cell Ltd., in which Elbit Medical holds approximately 30.8% of the voting power and a vast majority of Gamida Cell's shareholders (including Elbit Medical), signed Option and Investment Agreements with Novartis Pharma AG (Novartis). [More]
ASAHI INTECC, Boston Scientific to develop new, differentiated FFR wire

ASAHI INTECC, Boston Scientific to develop new, differentiated FFR wire

Boston Scientific Corporation and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. [More]
Using NMR to study protein motion: an interview with Fabien Ferrage, École Normale Supérieure, Paris

Using NMR to study protein motion: an interview with Fabien Ferrage, École Normale Supérieure, Paris

Can you give us a brief overview of the work you presented at ENC 2014 (Experimental Nuclear Magnetic Resonance Conference)? [More]
HUYA Bioscience International announces strategic partnership with CZCBD

HUYA Bioscience International announces strategic partnership with CZCBD

HUYA Bioscience International, a leader in accelerating the global development of China's pharmaceutical innovations, today announced a strategic partnership with the Changzhou Center for Biotech Development (CZCBD). [More]
Prime Healthcare completes acquisition of St. Mary's Hospital in Passaic, New Jersey

Prime Healthcare completes acquisition of St. Mary's Hospital in Passaic, New Jersey

Prime Healthcare announced today that it has completed its acquisition of St. Mary's Hospital in Passaic, New Jersey. [More]

Catasys total revenues up 192% in second quarter 2014

Catasys, Inc., provider of proprietary health management services to health insurers and employers, today announced its financial results for the second quarter ended June 30, 2014. [More]

ULURU reports revenues of $209,000 for second quarter 2014

ULURU Inc. today announced its financial results for the second quarter ended June 30, 2014 and provided a review of its operating activities. [More]

China Pharma Holdings' Q2 2014 revenue decreases by 24% to $6.1 million

China Pharma Holdings, Inc., an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced its financial results for the three months ended June 30, 2014. [More]
Dyadic's net product related revenue for Q2 2014 increases 28% to $4.9 million

Dyadic's net product related revenue for Q2 2014 increases 28% to $4.9 million

Dyadic International, Inc., a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, today announced financial results for the second quarter ended June 30, 2014. [More]

RBC Life Sciences net sales increase 18% to $7.9 million in second quarter 2014

RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, and wound care and pain management products, today reported consolidated net sales of $7.9 million for the quarter ended June 30, 2014, an 18% increase over net sales of $6.7 million in the second quarter of 2013. [More]
Novogen declares shareholder meeting results

Novogen declares shareholder meeting results

Australia-US biotechnology company, Novogen Ltd., an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia. [More]
Leica Biosystems, ACD co-market RNAscope LS ISH assays and BOND RX instrument

Leica Biosystems, ACD co-market RNAscope LS ISH assays and BOND RX instrument

Leica Biosystems and Advanced Cell Diagnostics, Inc. (ACD) have announced the co-marketing of ACD's RNAscope® LS ISH assays with Leica Biosystems' BOND RX research staining platform. [More]
HCN to acquire HealthLease REIT and 17 of Mainstreet's Next Generation properties

HCN to acquire HealthLease REIT and 17 of Mainstreet's Next Generation properties

The nation's largest post-acute health care developer and one of the world's largest health care real estate companies have agreed to join forces to lead the evolution of post-acute care, an emerging solution in the changing health care landscape. [More]
BDMS revenue increases 2.7% to $16.9M in second quarter 2014

BDMS revenue increases 2.7% to $16.9M in second quarter 2014

Birner Dental Management Services, Inc.,operators of PERFECT TEETH® dental practices, announced results for the quarter and six months ended June 30, 2014. [More]
Neovasc revenues increase 58% to $4,404,515 in Q2 2014

Neovasc revenues increase 58% to $4,404,515 in Q2 2014

Neovasc Inc. ("Neovasc" or the "Company") today announced financial results for the three months ended March 31, 2014. All results are reported in Canadian dollars unless otherwise stated. [More]